Journals / Journal of Medicine and Palliative Care / 2026 / Volume: 7 Issue: 3

Influenza and pneumococcal vaccination uptake, knowledge, and perceived necessity in adults with chronic diseases: a cross-sectional study

Derya Aslan Huyar(BURSA ULUDAĞ ÜNİVERSİTESİ, SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU, TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ, İLK VE ACİL YARDIM PR.)0000-0003-2916-7907
Pages
—
Publication Date
2026-06-25
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Targeted educational strategies and consistent physician engagement may improve vaccination coverage in high-risk populations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Influenza and pneumococcal infections cause substantial morbidity and mortality among adults with chronic diseases; however, vaccination coverage remains suboptimal despite strong international recommendations.
📊
Key Findings & Data:Methods: This descriptive cross-sectional study included adults (≥18 years) with at least one chronic disease attending an internal medicine outpatient clinic.
💡
Conclusion & Impact:Targeted educational strategies and consistent physician engagement may improve vaccination coverage in high-risk populations.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Influenza vaccination · pneumococcal vaccination · chronic disease

Abstract

Aims: Influenza and pneumococcal infections cause substantial morbidity and mortality among adults with chronic diseases; however, vaccination coverage remains suboptimal despite strong international recommendations. This study aimed to evaluate influenza and pneumococcal vaccination uptake, knowledge, attitudes, perceived necessity, and barriers among adults with chronic diseases. Methods: This descriptive cross-sectional study included adults (≥18 years) with at least one chronic disease attending an internal medicine outpatient clinic. Data were collected using a structured 11-item questionnaire assessing vaccination status, knowledge, physician recommendations, perceived necessity, and barriers. Associations were examined using Chi-square tests and Cramer’s V. Results: Among 200 participants, 49.00% had ever received an influenza vaccine and 20.50% were vaccinated in the previous year, while pneumococcal vaccination uptake was 14.60%. Awareness that influenza vaccination should be administered annually was reported by 30.50%, and 55.10% were aware of the pneumococcal vaccine. The most common barriers were lack of physician recommendation (57.90%), insufficient information (45.10%), and fear of adverse effects (41.40%). Knowledge of annual influenza vaccination was significantly associated with prior influenza vaccination (p<0.001; Cramer’s V=0.316). Pneumococcal vaccine recommendation was significantly associated with perceived necessity (χ²=19.68, df=6, p=0.003; Cramer's V=0.223). Conclusion: In this sample of adults with chronic diseases, only 20.50% had been vaccinated against influenza in the previous year and 14.60% had ever received a pneumococcal vaccine—well below guideline-recommended levels. Knowledge gaps and lack of physician recommendation emerged as the principal modifiable barriers. Targeted educational strategies and consistent physician engagement may improve vaccination coverage in high-risk populations.

🔖

Cite This Article

Şahin, M. F., Huyar, D. A. (2026). Influenza and pneumococcal vaccination uptake, knowledge, and perceived necessity in adults with chronic diseases: a cross-sectional study. Journal of Medicine and Palliative Care, Volume: 7 Issue: 3. https://doi.org/10.47582/jompac.1913543

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Durusu Tanrıöver M, Adaş M, Çiçekçioğlu H, et al. Burden of pneumococcal disease and adult vaccination landscape: an overview with data and policy ınsights from Türkiye. Infect Dis Clin Microbiol. 2025;7(4):337-349. doi:10.36519/idcm.2025.757
  2. Mirsaeidi M, Schraufnagel DE. Pneumococcal vaccines: understanding centers for disease control and prevention recommendations. Ann Am Thorac Soc. 2014;11(6):980-985. doi:10.1513/AnnalsATS.201401-042CME
  3. Lian R, Zhang H, An Y, Chen Z. Chronic diseases and influenza vaccines. Vaccines. 2025;13(9):936. doi:10.3390/vaccines13090936
  4. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule--United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(4):1-4.
  5. World Health Organization. Vaccines against influenza: WHO position paper—May 2022. Weekly Epidemiological Record. 2022;97(19):185-208.
  6. Lu PJ, Hung MC, Srivastav A, et al. Surveillance of vaccination coverage among adult populations -United States, 2018. MMWR Surveill Summ. 2021;70(3):1-26. doi:10.15585/mmwr.ss7003a1
  7. Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245-251. doi:10.1016/j.puhe.2021.02.025
  8. Ditzel K, Giardina F, Ten Oever J, Cremers AJ. Risk conditions for invasive pneumococcal disease in adults: a systematic review and meta-analysis. EClinicalMedicine. 2025;89:103522. doi:10.1016/j.eclinm.2025.103522
  9. Willis DE, Li J, Selig JP, et al. Healthcare provider recommendations for COVID-19 vaccination: prevalence, disparities, and correlates. Patient Educ Couns. 2025;130:108481. doi:10.1016/j.pec.2024.108481
  10. Chinchilla AH, Melton TC, Westrick SC, et al. A cross-sectional survey to identify current pneumococcal vaccination practices and barriers in rural community pharmacies. Vaccines. 2025;13(7):756. doi:10.3390/vaccines13070756
  11. Hunter P, Fryhofer SA, Szilagyi PG. Vaccination of adults in general medical practice. Elsevier; 2020:169-183.
  12. Melchinger H, Belgaumi SM, Ahmed N, Omer SB, Malik AA. Change in influenza vaccine uptake among adults in the United States from May 2020 to October 2024. PLOS Glob Public Health. 2025;5(7):e0004756. doi:10.1371/journal.pgph.0004756
  13. McAdam-Marx C, Tak C, Petigara T, et al. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting. BMC Health Serv Res. 2019;19(1):474. doi:10.1186/s12913-019-4263-2
  14. Abu-Helalah M, Gharibeh T, Al-Hanaktah M, et al. Knowledge, attitudes, barriers and uptake rate of influenza virus vaccine among adults with chronic diseases in Jordan: a multicentric cross-sectional study. Front Public Health. 2025;13:1603482. doi:10.3389/fpubh.2025.1603482
  15. Ayhan M, Kayaaslan B, Kaya Kalem A, Hasanoğlu İ, Güner HR. Knowledge, attitude and awareness toward influenza vaccination among patients admitted to the infectious diseases outpatient clinic of a research hospital. Flora. 2020;25(4):527-535. doi:10.5578/flora.69337
  16. Averin A, Vietri J, Mohs AA, Willis SJ, Lonshteyn A, Weycker D. Uptake of pneumococcal vaccines among United States adults following 2022 update to recommendations. AJPM Focus. 2025;4(5):100384. doi:10.1016/j.focus.2025.100384
  17. Adella GA, Abebe K, Atnafu N, et al. Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: multi-center study. Front Public Health. 2022;10: 917925. doi:10.3389/fpubh.2022.917925
  18. Napolitano F, Della Polla G, Capano MS, Augimeri M, Angelillo IF. Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy. Vaccines. 2020;8(4):560. doi:10.3390/vaccines8040560
  19. Nguyen KH. Report of health care provider recommendation for COVID-19 vaccination among adults, by recipient COVID-19 vaccination status and attitudes—United States, April–September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(50):1723-1730. doi:10.15585/mmwr.mm7050a1
  20. Liu Y, Liu T, Yao M, Kou Z, Li R. Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: a qualitative study. Hum Vaccin Immunother. 2024;20(1):2352916. doi:10.1080/21645515.2024.2352916
  21. Heinemeier D, Schmid P, Eitze S, Betsch C; Vaccination60+ study group. Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany. BMC Public Health. 2025;25(1):1672. doi:10.1186/s12889-025-22441-9
  22. Chitaree W, Buawangpong N, Yotruangsri T, Jiraporncharoen W, Pinyopornpanish K. Vaccine hesitancy affecting pneumococcal vaccine refusal in older adults with morbidities. J Prim Care Community Health. 2024;15:21501319241303568. doi:10.1177/21501319241303568
  23. Halsey G. Vaccine hesitancy in the chronic conditions community: new survey findings. Patient Care (Online). 2025.
  24. Xie J, Yan X, Zhang Q, et al. Analysis of influenza vaccination status and health information sources among middle-aged and older adults with multiple chronic diseases in Zhejiang, China: a cross-sectional study. Front Public Health. 2026;13:1719412. doi:10.3389/fpubh.2025.1719412
  25. Warren AM, Perrin PB, Elliott TR, Powers MB. Reasons for COVID-19 vaccine hesitancy in individuals with chronic health conditions. Health Sci Rep. 2022;5(2):e485. doi:10.1002/hsr2.485
  26. Ciemins EL, Jerry M, Powelson J, et al. An adult immunization best practices learning collaborative: impact, scale up, and spread. Popul Health Manag. 2020;23(6):459-466. doi:10.1089/pop.2019.0169
  27. UK UHSAG. Seasonal influenza vaccine uptake in GP patients in England: winter season 2023 to 2024. 2024.
  28. Frutos AM. Interim estimates of 2024–2025 seasonal influenza vaccine effectiveness—four vaccine effectiveness networks, United States, October 2024–February 2025. MMWR Morb Mortal Wkly Rep. 2025; 74(6):83-90. doi:10.15585/mmwr.mm7406a2
  29. Presa J, Arranz-Herrero J, Alvarez-Losa L, et al. Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention. Eur Respir Rev. 2025;34(175):240144. doi:10.1183/16000617.0144-2024
  30. Özsoy M, Bilgin G, Arslan İ, Baştuğ ÖA, Cesur S. Assessment of vaccination rates and attitudes toward pneumococcal, influenza, and COVID-19 vaccines among asthmatic patients and adults aged 65 years and older without asthma. J Med Palliat Care. 2025;6(4):332-338. doi:10.47582/jompac.1697712